
亚太地区医用聚甲醛市场预测至 2028 年 - COVID-19 影响和应用区域分析(透析机、手术器械手柄、吸入器、胰岛素笔等)
No. of Pages: 98 | Report Code: TIPRE00023485 | Category: Chemicals and Materials
No. of Pages: 98 | Report Code: TIPRE00023485 | Category: Chemicals and Materials
亚太大陆由印度、中国、日本、韩国、澳大利亚等多个发展中经济体组成。这些新兴国家正在见证工业化和城市化活动的蓬勃发展,为医用聚甲醛市场的主要市场参与者提供了充足的机会。多年来,亚太地区国家的医用聚甲醛行业经历了相当大的转变。亚太地区市场的大幅增长得益于印度和中国等新兴经济体对先进医疗设施和基础设施的投资不断增加。中国、日本和印度强大的工程塑料制造基地以及各种应用基地对聚甲醛的高需求预计将促进区域市场的增长。此外,印度政府和印度制造的利好政策预计将为医疗保健行业创造充足的增长机会,进而有望增加该地区医用聚甲醛的消费量。此外,组织工程应用的兴起是推动亚太地区医用聚甲醛市场增长的主要因素。
预计 COVID-19 将在亚太地区造成重大经济损失。随着病毒的传播,后果和影响可能会恶化。亚太各国政府于2020年初实施封锁,以限制病毒的传播,这反过来对医用聚甲醛市场收入产生了负面影响。持续的 COVID-19 大流行严重影响了医用聚甲醛行业的增长前景。由于国家和国际边界突然关闭,疫情扭曲了运营效率并扰乱了价值链,导致收入损失和损害。由于价值链中断,原材料供应受到影响。然而,随着经济体计划重新启动运营,预计未来几个月对医用聚甲醛的需求将会增加。然而,对准时生产的重视是阻碍亚太地区医用聚甲醛市场增长的另一个因素。
亚太地区医用聚甲醛市场预计到2028年将从34,330,620美元增至47,426,650美元2020 年。预计 2020 年至 2028 年市场复合年增长率为 4.1%。医疗保健相关感染 (HCAI) 或医院感染是与医疗程序期间使用的设备和装置(例如导管或呼吸机)相关的感染。在此期间,HCAI疾病的患病率不断上升,已成为各个经济体的严重关切。 HCAI 给医疗机构带来了重大的健康挑战,HCAI 引起的病症是西方国家第六大死因,在其他发展中经济体甚至更高。
亚太地区医用聚甲醛市场分为应用和国家。根据应用,亚太地区医用聚甲醛市场分为透析机、手术器械手柄、吸入器、胰岛素笔等。胰岛素笔细分市场在 2019 年占据市场主导地位。此外,吸入器细分市场预计将成为预测期内增长最快的细分市场。
准备本亚太地区医用聚甲醛市场报告时提到的一些主要一手和二手来源包括公司网站、年度报告、财务报告、国家政府文件和统计数据库等。报告中列出的主要公司有巴斯夫股份公司(BASF SE);塞拉尼斯公司;杜邦德内穆尔公司;恩欣格; Inventro聚合物;可隆塑料;韩国工程塑料有限公司; LG化学;三菱化学公司;和宝理塑料株式会社等。
亚太地区医用聚甲醛市场 - 按应用
Strategic insights for Asia Pacific Medical Polyoxymethylene involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2020 | US$ 34,330.62 thousand |
Market Size by 2028 | US$ 47,426.65 thousand |
Global CAGR (2020 - 2028) | 4.1% |
Historical Data | 2018-2019 |
Forecast period | 2021-2028 |
Segments Covered |
By 应用
|
Regions and Countries Covered | 亚太地区
|
Market leaders and key company profiles |
The regional scope of Asia Pacific Medical Polyoxymethylene refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Asia Pacific Medical Polyoxymethylene Market is valued at US$ 34,330.62 thousand in 2020, it is projected to reach US$ 47,426.65 thousand by 2028.
As per our report Asia Pacific Medical Polyoxymethylene Market, the market size is valued at US$ 34,330.62 thousand in 2020, projecting it to reach US$ 47,426.65 thousand by 2028. This translates to a CAGR of approximately 4.1% during the forecast period.
The Asia Pacific Medical Polyoxymethylene Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Medical Polyoxymethylene Market report:
The Asia Pacific Medical Polyoxymethylene Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Medical Polyoxymethylene Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Medical Polyoxymethylene Market value chain can benefit from the information contained in a comprehensive market report.